Law360, New York (July 01, 2009) -- A biotechnology patent-holding company has sued Pfizer Inc. alleging the drugmaker infringed patents related to components of Alzheimer’s disease research, including nucleic acid coding for the so-called Swedish mutation and genetically engineered mice expressing the mutation.
The Alzheimer’s Institute of America Inc. filed its complaint on Tuesday in the U.S. District Court for the Eastern District of Missouri asserting that Pfizer has infringed U.S. Patent Numbers...
